These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 20972969)
1. Injection laryngoplasty with micronized dermis: a 10-year experience with 381 injections in 344 patients. Tan M; Woo P Laryngoscope; 2010 Dec; 120(12):2460-6. PubMed ID: 20972969 [TBL] [Abstract][Full Text] [Related]
2. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients. Yung KC; Likhterov I; Courey MS Laryngoscope; 2011 Oct; 121(10):2191-4. PubMed ID: 21898421 [TBL] [Abstract][Full Text] [Related]
3. Injection Laryngoplasty Using Micronized Acellular Dermis for Vocal Fold Paralysis: Long-term Voice Outcomes. Hernandez SC; Sibley H; Fink DS; Kunduk M; Schexnaildre M; Kakade A; McWhorter AJ Otolaryngol Head Neck Surg; 2016 May; 154(5):892-7. PubMed ID: 26932966 [TBL] [Abstract][Full Text] [Related]
4. Posterior glottic gap and age as factors predicting voice outcome of injection laryngoplasty in patients with unilateral vocal fold paralysis. Choi J; Son YI; So YK; Byun H; Lee EK; Yun YS J Laryngol Otol; 2012 Mar; 126(3):260-6. PubMed ID: 22017979 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of fat injection laryngoplasty for unilateral vocal cord paralysis. McCulloch TM; Andrews BT; Hoffman HT; Graham SM; Karnell MP; Minnick C Laryngoscope; 2002 Jul; 112(7 Pt 1):1235-8. PubMed ID: 12169905 [TBL] [Abstract][Full Text] [Related]
6. Allograft (Alloderm) and autograft (temporalis fascia) implantation for glottic insufficiency: a novel approach. Tan M; Bassiri-Tehrani M; Woo P J Voice; 2011 Sep; 25(5):619-25. PubMed ID: 21051201 [TBL] [Abstract][Full Text] [Related]
8. Arytenoid adduction with medialization laryngoplasty versus injection or medialization laryngoplasty: the role of the arytenoidopexy. Mortensen M; Carroll L; Woo P Laryngoscope; 2009 Apr; 119(4):827-31. PubMed ID: 19263407 [TBL] [Abstract][Full Text] [Related]
14. Patient-defined duration of benefit from juvederm (hyaluronic acid) used in injection laryngoplasty. Bertroche JT; Radder M; Kallogjeri D; Paniello RC; Bradley JP Laryngoscope; 2019 Dec; 129(12):2744-2747. PubMed ID: 30698821 [TBL] [Abstract][Full Text] [Related]
15. Voice outcomes of polyacrylamide hydrogel injection laryngoplasty. Lee SW; Son YI; Kim CH; Lee JY; Kim SC; Koh YW Laryngoscope; 2007 Oct; 117(10):1871-5. PubMed ID: 17690620 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of office-based injection laryngoplasty with hyaluronic acid gel. Upton DC; Johnson M; Zelazny SK; Dailey SH Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):541-6. PubMed ID: 24224395 [TBL] [Abstract][Full Text] [Related]
17. Early versus late injection medialization for unilateral vocal cord paralysis. Friedman AD; Burns JA; Heaton JT; Zeitels SM Laryngoscope; 2010 Oct; 120(10):2042-6. PubMed ID: 20824787 [TBL] [Abstract][Full Text] [Related]
19. A Novel Approach to the Challenging Injection Laryngoplasty. Mayerhoff RM; Kuo C; Meyer T Ann Otol Rhinol Laryngol; 2016 May; 125(5):415-20. PubMed ID: 26658069 [TBL] [Abstract][Full Text] [Related]
20. Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis. Morgan JE; Zraick RI; Griffin AW; Bowen TL; Johnson FL Laryngoscope; 2007 Nov; 117(11):2068-74. PubMed ID: 17828043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]